¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"B cell/lymphocyte"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
sensitized lymphocyte
¹Î°¨È¸²ÇÁ±¸
acantholytic cell
°¡½Ã¼¼Æ÷ºÐ¸®¼¼Æ÷
angioimmunoblastic T-cell lymphoma
Ç÷°ü¸é¿ª¸ð±¸T¼¼Æ÷¸²ÇÁÁ¾
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
antibody-producing cell
Ç×ü»ý»ê¼¼Æ÷
antibody-screening cell
Ç×ü¼±º°Ç÷±¸
antigen-presenting cell
Ç׿øÁ¦½Ã¼¼Æ÷
antigen-reactive cell
Ç׿ø¹ÝÀÀ¼¼Æ÷
antigen-recognizing cell
Ç׿øÀÎÁö¼¼Æ÷
argentaffin cell
ÀºÄ£È¼¼Æ÷
argyrophilic cell
ÀºÄ£È¼¼Æ÷
asexual cell
¹«¼º¼¼Æ÷
acidophilic cell
È£»ê¼¼Æ÷
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ethmoidal cell
¹úÁý»À¹úÁý
eukaryotic cell
ÁøÇÙ¼¼Æ÷
goblet cell
¼úÀܼ¼Æ÷
hair cell
Åм¼Æ÷
inflammatory cell
¿°Áõ¼¼Æ÷
killer cell
»ìÇØ¼¼Æ÷
Kupffer's cell
º°Å«Æ÷½Ä¼¼Æ÷, ÄíÆÛ¼¼Æ÷
mast cell
ºñ¸¸¼¼Æ÷
mesenchymal cell
Áß°£¿±¼¼Æ÷
mesothelial cell
ÁßÇǼ¼Æ÷
mother cell
¸ð¼¼Æ÷, ¾î¹Ì¼¼Æ÷
neuroendocrine cell
½Å°æ³»ºÐºñ¼¼Æ÷
packed red blood cell
³óÃàÀûÇ÷±¸
parietal cell
º®¼¼Æ÷
perivascular cell
Ç÷°üÁÖÀ§¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
thymus-derived lymphocyte
°¡½¿»ùÀ¯·¡¸²ÇÁ±¸
mixed lymphocyte reaction
¸²ÇÁ±¸È¥ÇÕ¹è¾ç¹ÝÀÀ
mixed lymphocyte culture test
È¥ÇÕ¸²ÇÁ±¸¹è¾ç°Ë»ç
monocyte lymphocyte ratio
´ÜÇÙ±¸¸²ÇÁ±¸ºñÀ²
primed lymphocyte typing
ÃÊȸÇ׿øÀÚ±ØÈĸ²ÇÁ±¸Çüº°È
primed lymphocyte-typing test
°¨ÀÛ¸²ÇÁ±¸Çüº°°Ë»ç
acantholytic cell
°¡½Ã¼¼Æ÷ÇØ¸®¼¼Æ÷
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
acidophilic cell
È£»ê¼º¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
acinic cell carcinoma
»ù²Ê¸®¼¼Æ÷¾ÏÁ¾, ¼¼¿±¼¼Æ÷¾ÏÁ¾
amacrine cell
¹«Ãà»è¼¼Æ÷
ameboid cell
¾Æ¸Þ¹Ù¸ð¾ç¼¼Æ÷
annular elastotic giant cell granuloma
°í¸®Åº·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾, ȯ»óź·Â¼¶À¯°Å´ë¼¼Æ÷À°¾ÆÁ¾
antibody-dependent cell-mediated cytotoxicity
Ç×üÀÇÁ¸¼¼Æ÷¸Å°³¼¼Æ÷µ¶¼º
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
NK cell [=natural killer cell]
ÀÚ¿¬»ì»ó¼¼Æ÷
alpha cell glucagon cell
¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
quiescent cell, Q cell
Á¤Áö¼¼Æ÷
A cell
A ¼¼Æ÷
B cell
B¼¼Æ÷(~ á¬øà)
B cell
B ¼¼Æ÷
B cell
B ¼¼Æ÷.
B cell antigen
B ¼¼Æ÷Ç׿ø
B cell differentiation factor (BCDF)
B¼¼Æ÷ ºÐÈÀ¯¹ßÀÎÀÚ
B cell growth factor
B ¼¼Æ÷¼ºÀåÀÎÀÚ
B cell growth factor (BCGF)
B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
B cell hybridoma
B¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
B cell lymphoma
B¼¼Æ÷¸²ÇÁÁ¾
B cell stimulating factor (BSF)
B¼¼Æ÷ ÀÚ±ØÀÎÀÚ
B cell study
B ¼¼Æ÷°Ë»ç
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
lymphocyte
¸²ÇÁ±¸
lymphocyte activating factor
¸²ÇÁ±¸È°¼ºÀÎÀÚ
lymphocyte activating factor (LAF)
¸²ÇÁ±¸ Ȱ¼ºÈÀÎÀÚ
lymphocyte analysis
¸²ÇÁ±¸ºÐ¼®
lymphocyte culture, mixed
È¥ÇÕ ¸²ÇÁ±¸¹è¾ç
lymphocyte defined antigen
¸²ÇÁ±¸±ÔÁ¤Ç׿ø.
lymphocyte development
¸²ÇÁ±¸¹ßÀ°
lymphocyte dysfunction
¸²ÇÁ±¸±â´ÉÀå¾Ö<--ºÎÀü>
lymphocyte inhibitory factor (LIF)
¸²ÇÁ±¸¾ïÁ¦ÀÎÀÚ
lymphocyte interaction
¸²ÇÁ±¸»óÈ£ÀÛ¿ë.
lymphocyte microcytotoxicity assay
¸²ÇÁ±¸¼Ò¼¼Æ÷µ¶¼º°Ë»ç
lymphocyte production
¸²ÇÁ±¸»ý¼º
lymphocyte proliferation
¸²ÇÁ±¸Áõ½Ä
lymphocyte transformation
¸²ÇÁ±¸Àüȯ(¡Ï¹ ï®üµ).
lymphocyte, resident
»óÁÖ¸²ÇÁ±¸
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½